| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/19/1995 | EP0662840A1 Pharmaceutical compositions and methods for treating cold symptoms |
| 07/19/1995 | CA2140498A1 Method for preventing or reducing risk of onset of cardiovascular events employing an hmg coa reductase |
| 07/18/1995 | US5434287 Bifunctional DTPA-type ligand |
| 07/18/1995 | US5434131 Chimeric CTLA4 receptor and methods for its use |
| 07/18/1995 | US5434086 Method of testing potential cystic fibrosis treating compounds using cells in culture |
| 07/13/1995 | WO1995018635A1 Low molecular weight hyaluronic acid with peptide or protein |
| 07/13/1995 | WO1995018627A1 Method of making polymers having specific properties |
| 07/13/1995 | WO1995018617A1 1-aminoindan derivatives and compositions thereof |
| 07/13/1995 | WO1995018614A1 Method for treatment of obesity using prolactin modulators and diet |
| 07/12/1995 | EP0662130A1 A method of producing hepatocyte growth factor and a cell line |
| 07/12/1995 | EP0661991A1 Methods for treating renin-related disorders with amylin antagonists |
| 07/12/1995 | EP0661967A1 Combined virustatic antimediator (covam) treatment of common colds |
| 07/12/1995 | CN1104890A Cation-complexed polysacharides |
| 07/12/1995 | CN1104889A Cessation of tobacco use |
| 07/11/1995 | US5432168 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 07/11/1995 | US5432162 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA) |
| 07/11/1995 | US5431925 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 07/11/1995 | US5431902 New medicament aerosol formulation based on fusafungine |
| 07/11/1995 | CA1336272C Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
| 07/11/1995 | CA1336264C Pharmaceutical compositions containing deoxyribonucleosides for wound healing |
| 07/06/1995 | WO1995018132A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 07/06/1995 | WO1995017911A1 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 07/06/1995 | WO1995017901A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 07/06/1995 | WO1995017899A2 Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread |
| 07/06/1995 | WO1995017895A1 Means and method for hormonal contraception and/or the treatment of acne |
| 07/06/1995 | WO1995017887A1 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 07/06/1995 | WO1995016435A3 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
| 07/06/1995 | CA2180260A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 07/06/1995 | CA2180019A1 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 07/06/1995 | CA2180014A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 07/06/1995 | CA2179422A1 Means and method for hormonal contraception and/or the treatment of acne |
| 07/05/1995 | EP0661038A1 Depigmentation composition for the simultaneous treatment of the superficial skinlayers and the deep skinlayers |
| 07/05/1995 | EP0661037A1 Composition against skinaging acting simultaneously on the superficial and deep skinlayers |
| 07/05/1995 | EP0661036A1 Antiacne composition for the simultaneous treatment of superficial and lower layers of the skin |
| 07/05/1995 | EP0660711A1 Novel use of inhibitors of phosphodiestersase iv |
| 07/05/1995 | EP0660710A1 Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals |
| 07/04/1995 | US5430045 Administering an L-2-oxothiazolidine-4-carboxylate to patient receiving AZT |
| 07/04/1995 | CA1336168C Method of preventing or treating toxemia in pregnancy using a thromboxane a_ receptor antagonist |
| 07/04/1995 | CA1336166C Further improvements relating to drug delivery systems |
| 07/01/1995 | CA2138876A1 Composition against aging by acting simultaneously on the superficial and deep layers of the skin, and its use |
| 07/01/1995 | CA2138875A1 Depigmentation composition for the simultaneous treatment of the superficial and deep layers of the skin, and its use |
| 06/30/1995 | CA2112539A1 Medicated herbal lotion |
| 06/29/1995 | WO1995017378A1 Compound capable of introducing at least one molecule into a cell |
| 06/29/1995 | WO1995017188A1 Deuterised active agents in transdermal application |
| 06/29/1995 | WO1995017183A1 Use of pla2 inhibitors as treatment for alzheimer's disease |
| 06/29/1995 | WO1995017178A1 Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure |
| 06/29/1995 | WO1995017170A1 Accelerated release composition containing bromocriptine |
| 06/29/1995 | WO1995017093A1 New cryptophycins |
| 06/29/1995 | WO1995011013A3 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 06/29/1995 | CA2179649A1 Use of pla2 inhibitors as treatment for alzheimer's disease |
| 06/29/1995 | CA2179490A1 New cryptophycins |
| 06/29/1995 | CA2179385A1 Compound capable of introducing at least one molecule into a cell |
| 06/28/1995 | EP0659421A1 2-Phenyl-3-azoylbenzothiophenes for treating menstrual symptoms |
| 06/28/1995 | EP0659402A2 Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
| 06/28/1995 | EP0659211A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 06/28/1995 | EP0659082A1 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 06/27/1995 | US5428070 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity |
| 06/27/1995 | US5428069 Treating cognition with, aminocyclopropanecarboxylic derivatives |
| 06/27/1995 | US5428033 Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 06/27/1995 | US5428031 Benzodiazepine analogs; cardiovascular disorders |
| 06/27/1995 | US5427767 Particles having crosslinked coatings of natural or synthetic mucopolysaccharides, for contrast in nuclear magnetic resonance imaging |
| 06/22/1995 | WO1995016775A1 Tumor cell fusions and methods for use of such tumor cell fusions |
| 06/22/1995 | WO1995016706A1 Interleukin-1 receptor antagonist decreases severity of acute pancreatitis |
| 06/22/1995 | WO1995016675A1 Benzo-fused lactams promote release of growth hormone |
| 06/22/1995 | WO1995016464A1 Controlled release of pharmaceutically active substances for immunotherapy |
| 06/22/1995 | WO1995016452A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems |
| 06/22/1995 | WO1995016449A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| 06/22/1995 | WO1995016435A2 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
| 06/22/1995 | WO1995015381A3 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer |
| 06/22/1995 | WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 06/22/1995 | CA2179147A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
| 06/22/1995 | CA2179006A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| 06/22/1995 | CA2178950A1 Tumor cell fusions and methods for use of such tumor cell fusions |
| 06/22/1995 | CA2178902A1 Controlled release of pharmaceutically active substances for immunotherapy |
| 06/22/1995 | CA2174729A1 A method of preventing depletion of non-autologous hematopoietic cells and animal model systems for use thereof |
| 06/22/1995 | CA2138100A1 Methods of treating menstrual symptoms and compositions therefor |
| 06/21/1995 | EP0658110A1 Use of norastemizole for the treatment of allergic disorders |
| 06/21/1995 | EP0540588B1 A composition providing improved clearance of bioactive substances from the bloodstream |
| 06/20/1995 | US5426109 Phenylnaphthalene hydroxy acids |
| 06/15/1995 | WO1995015979A1 Pretargeting methods and compounds |
| 06/15/1995 | WO1995015978A1 Pretargeting methods and compounds |
| 06/15/1995 | WO1995015756A1 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors |
| 06/15/1995 | WO1995015755A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent |
| 06/15/1995 | WO1995015753A1 Ovulation control by regulating nitric oxide levels |
| 06/15/1995 | WO1995015747A1 Local delivery of fibrinolysis enhancing agents |
| 06/15/1995 | WO1995014028A3 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 06/15/1995 | WO1995012678A3 Improvements relating to cancer therapy |
| 06/15/1995 | CA2178477A1 Pretargeting methods and compounds |
| 06/15/1995 | CA2178476A1 Pretargeting methods and compounds |
| 06/14/1995 | EP0657029A1 Calcium receptor active molecules |
| 06/14/1995 | EP0656952A1 Cationic peptides and method for production |
| 06/14/1995 | EP0656944A1 Human melanocyte stimulating hormone receptor |
| 06/14/1995 | EP0656786A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 06/13/1995 | US5424320 Heteroaryl coumarins as inhibitors of leukotriene biosynthesis |
| 06/13/1995 | US5424187 Detection of chlamydial markers for diagnosis of infections in coronary arteries |
| 06/13/1995 | EP0724449A4 Preservative for pharmaceutical products |
| 06/13/1995 | CA1335883C Enhancement of the cellular immune response |
| 06/08/1995 | WO1995015381A2 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 06/08/1995 | WO1995015341A1 Antibody against carcinoembryonic antigen (cea) |